Gene Editing(BK4556),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BK4556 Gene Editing

Market Closed 01-09 16:00:00 EST

445.15

-14.82

-3.22%

High470.26	Low442.83	Vol14.05M
Open460.07	D1 Closing459.98	Amplitude5.96%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O221.75M	T/O Rate--	Tradable Shares0.00
P/B2.662189	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK4556","market":"US","secType":"PLATE","nameCN":"Gene Editing","latestPrice":445.15366,"timestamp":1767992399999,"preClose":459.9781,"halted":0,"volume":14046233,"delay":0,"changeRate":-0.032229,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":-14.824432,"latestTime":"01-09 16:00:00 EST","open":460.06976,"high":470.26483,"low":442.8305,"amount":221746065.570024,"amplitude":0.059643,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1768208400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":2.662189,"peRate":-5.862638,"turnoverRate":0.021057,"increases":0,"decrements":5,"flats":0,"marketCap":9479472384,"floatMarketCap":8726593960},"requestUrl":"/m/hq/s/BK4556","defaultTab":"news","newsList":[{"id":"2601389855","title":"Intellia Therapeutics VP and Chief Accounting Officer Michael P. Dube Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2601389855","media":"Reuters","labels":["insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601389855?lang=en_us&edition=fundamental","pubTime":"2026-01-08 05:02","pubTimestamp":1767819755,"startTime":"0","endTime":"0","summary":"Michael P. Dube, Vice President and Chief Accounting Officer of Intellia Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intellia Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 07, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nNDL1rLNf7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Intellia Therapeutics VP and Chief Accounting Officer Michael P. Dube Reports Disposal of Common Shares","news_tag":"insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","LU1861558580.USD","LU1861559042.SGD","BK4585","BK4588","BK4556","BK4139","NTLA"],"gpt_icon":0},{"id":"2600098287","title":"Intellia Therapeutics Awards Inducement Grants to New Employees","url":"https://stock-news.laohu8.com/highlight/detail?id=2600098287","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600098287?lang=en_us&edition=fundamental","pubTime":"2026-01-03 05:01","pubTimestamp":1767387678,"startTime":"0","endTime":"0","summary":"Intellia Therapeutics announced the awarding of inducement grants to two new employees under its 2024 Inducement Plan. The grants include time-based restricted stock units  totaling 22,800 shares of Intellia's common stock. One-third of the RSUs will vest annually over three years, contingent on continued service with the company. These awards were granted outside of Intellia's stockholder-approved equity incentive plans.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intellia Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on January 02, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260102:nNDL6jPH0q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","SG9999014013.SGD","LU2210149790.SGD","LU2095319765.USD","SG9999014005.SGD","BK4556","NTLA","BK4112","IE00BGHQF748.EUR","BK4535","BK4588","IE00B64PRP62.GBP","SG9999014021.USD","LU1861558580.USD","NDAQ","SG9999014039.USD","IE00BKPKM429.USD","BK4139","IE00B3QW5Z07.USD","LU0314104364.USD","BK4585","LU1861559042.SGD"],"gpt_icon":0},{"id":"2600702098","title":"Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2600702098","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600702098?lang=en_us&edition=fundamental","pubTime":"2026-01-03 05:01","pubTimestamp":1767387660,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., Jan.  02, 2026  (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/02/3212275/0/en/Intellia-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTLA","BK4535","BK4585","LU1861559042.SGD","BK4556","BK4139","LU1861558580.USD","BK4588"],"gpt_icon":0},{"id":"2600040807","title":"Cathie Wood's Biotech Trend: Twist, Beam, CRISPR Latest Stock Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2600040807","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600040807?lang=en_us&edition=fundamental","pubTime":"2026-01-01 06:06","pubTimestamp":1767218760,"startTime":"0","endTime":"0","summary":"The massive rotation currently unfolding within ARK Invest suggests that Cathie Wood thinks 2026 will be the year of the genomic revolution.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/31/Cathie-Wood-Doubles-Down-On-Bitcoin-ETF-.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/31/Cathie-Wood-Doubles-Down-On-Bitcoin-ETF-.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/etfs/specialty-etfs/25/12/49657695/cathie-woods-biotech-trend-twist-beam-crispr-latest-stock-picks","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/etfs/specialty-etfs/25/12/49657695/cathie-woods-biotech-trend-twist-beam-crispr-latest-stock-picks","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["LU0234572021.USD","LU1066051225.USD","IE00BK4W5L77.USD","LU1720051017.SGD","IE00B19Z8X17.USD","LU1839511570.USD","LU0820562030.AUD","LU0823414478.USD","LU0234570918.USD","SG9999015952.SGD","LU2108987350.USD","LU2750360997.AUD","LU1145028129.USD","LU2360107168.USD","BK4555","BK4612","LU2471134796.USD","BK4550","BK4511","BK4585","IE00BSNM7G36.USD","BK4564","LU2403377893.USD","BK4099","BK4534","BK4187","NTLA","LU2456880835.USD","LU0964807845.USD","BK4581","LU2756315318.SGD","LU0198837287.USD","BK4556","LU1720051108.HKD","LU1548497426.USD","USAW.SI","LU1435385759.SGD","LU2756315664.SGD","LU1551013342.USD","IE00B19Z9505.USD","LU0082616367.USD","LU2471134952.CNY","LU0345770308.USD","LU0345769631.USD","TQQQ","LU1914381329.SGD","BEAM","LU0708995401.HKD","BK4592","LU0345770993.USD","LU2462157665.USD","LU0672654240.SGD","IE0034235303.USD","BK4551","LU1674673691.USD","SQQQ","LU1066051498.USD","IE00B1XK9C88.USD","IE00B1BXHZ80.USD","LU1674673428.USD","LU1861220033.SGD","BK4588","LU0323591593.USD","LU1429558221.USD","MNQmain","BK4543","LU2290526834.HKD","LU2250418816.HKD","BK4574","QID","LU2249611893.SGD","BK4535","CRSP","LU1066053197.SGD","LU2420271590.USD","SG9999015986.USD","LU1852331112.SGD","LU2213496289.HKD","LU1267930730.SGD","LU1366192091.USD","LU1066051811.HKD","LU0466842654.USD","LU2357305700.SGD","LU2602419157.SGD","ARKK","LU0316494557.USD","LU0210536198.USD","TSYW.SI","LU2087621335.USD","LU2896262040.SGD","LU1778281490.HKD","LU1551013425.SGD","BK4505","USJW.SI","LU1861558580.USD","IE00B19Z8W00.USD","BK4548","LU2471134879.HKD","LU0056508442.USD","PACB","BK4527","LU2063271972.USD","LU0345769128.USD","LU2326559502.SGD","LU2417539215.USD","IE00BJLML261.HKD","SG9999015978.USD","BK4611","BK4139","LU0823411888.USD","LU1629891620.HKD","LU2023250330.USD","LU2471134523.USD","LU0320765059.SGD","IE00BK4W5M84.HKD","LU2360106780.USD",".IXIC","TWST","BK4533","LU0689472784.USD","BK4516","PSQ","LU1232071149.USD","NVIW.SI","BK4604","LU0077335932.USD","LU2236285917.USD","QLD","LU2750360641.GBP","SG9999015945.SGD","BK4121","BK4598","BK4544","LU0097036916.USD","LU0109391861.USD","LU0943347566.SGD","LU0053666078.USD","LU0719512351.SGD","LU0820561909.HKD","LU1861215975.USD","LU1861559042.SGD","NQmain","IE00BWXC8680.SGD","LU0348723411.USD","LU0820561818.USD"],"gpt_icon":1},{"id":"2593344655","title":"CRISPR Therapeutics CFO Prasad Raju Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2593344655","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593344655?lang=en_us&edition=fundamental","pubTime":"2025-12-24 06:34","pubTimestamp":1766529242,"startTime":"0","endTime":"0","summary":"Raju Prasad, Chief Financial Officer of CRISPR Therapeutics AG, reported a disposal of common shares of the company, according to a recent regulatory filing. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CRISPR Therapeutics AG published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 23, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nNDL5d4Df:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"CRISPR Therapeutics CFO Prasad Raju Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRSP","BK4611","BK4588","LU1861558580.USD","BK4139","BK4556","LU1861559042.SGD","BK4585"],"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":0.016},{"period":"1month","weight":0.0095},{"period":"3month","weight":0.0629},{"period":"6month","weight":0.113},{"period":"1year","weight":0.1774},{"period":"ytd","weight":0.0178}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"name":"BK4556","nameEN":"BK4556"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Gene Editing(BK4556),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Gene Editing(BK4556) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Gene Editing,BK4556,Gene Editing股票,Gene Editing股票老虎,Gene Editing股票老虎国际,Gene Editing行情,Gene Editing股票行情,Gene Editing股价,Gene Editing股市,Gene Editing股票价格,Gene Editing股票交易,Gene Editing股票购买,Gene Editing股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Gene Editing(BK4556),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Gene Editing(BK4556) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction